{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:33:12Z","timestamp":1790375592140,"version":"4.1.0"},"reference-count":98,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"National Cancer Center Research and Development Fund"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2019,3,4]]},"DOI":"10.1080\/14712598.2019.1572746","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:08:58Z","timestamp":1547856538000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":32,"title":["Development of new agents for peripheral T-cell lymphoma"],"prefix":"10.1080","volume":"19","clinical-trial-number":[{"clinical-trial-number":"nct01796002","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00865969","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01728805","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01578499","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01998035","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00364923","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01947140","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02697552","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01777152","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03593018","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01482962","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01897012","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02955589","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02232516","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02953652","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yuta","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital,\r      Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6609-8088","authenticated-orcid":false,"given":"Shinichi","family":"Makita","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital,\r      Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital,\r      Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"CIT0001","volume-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2016"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh392"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14477"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7524"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.321"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1306642"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-390211"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8470"},{"key":"CIT0010","first-page":"3493","volume":"6","author":"Krug LM","year":"2000","journal-title":"Clin Cancer Res"},{"key":"CIT0011","first-page":"2072","volume":"9","author":"Krug LM","year":"2003","journal-title":"Clin Cancer Res"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.80"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13855"},{"key":"CIT0015","first-page":"9","volume-title":"ASH annual meeting","author":"Shustov AR","year":"2017"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.47.315"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4027"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1046\/j.1359-4117.2002.01039.x"},{"key":"CIT0019","first-page":"718","volume":"8","author":"Sandor V","year":"2002","journal-title":"Clin Cancer Res"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6150"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-312603"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.4223"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-7-11"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.9066"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00023-X"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2782"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-780049"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-542142"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.2456"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-821009"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32984-2"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31266-7"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv237"},{"key":"CIT0035","volume-title":"ASH annual meeting","author":"Onizuka M","year":"2016"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1347634"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2401"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13338"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.0924"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.146977"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30379-6"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)91950-9"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu231"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S140756"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2012.02287.x"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3418-2"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1038\/nature04431"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30149-9"},{"key":"CIT0050","volume-title":"ASH annual meeting","author":"Maruyama D","year":"2017"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1536"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2305-8"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.8793"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.6327"},{"key":"CIT0055","volume-title":"ASH annual meeting","author":"O\u2019Connor OA","year":"2015"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2926"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200725"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-786566"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802470"},{"key":"CIT0061","volume-title":"ASH annual meeting","author":"Oki Y","year":"2016"},{"key":"CIT0062","volume-title":"ASH annual meeting","author":"Oki Y","year":"2017"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-110416-120628"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7025"},{"key":"CIT0065","volume-title":"ASH annual meeting","author":"Moskowitz AJ","year":"2018"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.77"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3719"},{"key":"CIT0068","volume-title":"ASH annual meeting","author":"Horwitz SM","year":"2018"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.01.016"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3018"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-629543"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv624"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805104"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.7732"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.04.029"},{"key":"CIT0076","unstructured":"Northwestern University. Romidepsin and       lenalidomide in treating patients with previously untreated peripheral T-cell       lymphoma. ClinicalTrials.gov. Bethesda       (MD): National Library of Medicine (US).\n      NLM Identifier: NCT02232516. [cited 2019        Jan 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02232516."},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1111708"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2872"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-840538"},{"key":"CIT0080","unstructured":"The\n       Lymphoma Academic Research Organization. Efficacy and       safety of oral azacitidine compared to investigator\u2019s choice therapy in patients with       relapsed refractory AITL. ClinicalTrials.gov.\n      Bethesda (MD): National Library of Medicine       (US). [cited 2019 Jan 15]. NLM Identifier: NCT03593018.\n      Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03593018."},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7568"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13239"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1407898"},{"key":"CIT0085","volume-title":"ASH Annual meeting","author":"Maciocia PM","year":"2016"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2249"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806737"},{"key":"CIT0088","unstructured":"Columbia University. Pralatrexate +       romidepsin in relapsed\/refractory lymphoid malignancies (PDX+Romi).\n      ClinicalTrials.gov. Bethesda (MD):\n      National Library of Medicine (US). NLM Identifier:       NCT01947140. [cited 2019 Jan 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01947140."},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336891"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1435"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13566"},{"key":"CIT0092","volume-title":"ASH annual meeting","author":"Falchi L","year":"2017"},{"key":"CIT0093","volume-title":"ASH annual meeting","author":"Falchi L","year":"2018"},{"key":"CIT0094","unstructured":"Columbia University. Romidepsin plus oral       5-azacitidine in relapsed\/refractory lymphoid malignancies.\n      ClinicalTrials.gov. Bethesda (MD):\n      National Library of Medicine (US). NLM Identifier:       NCT01998035. [cited 2019 Jan 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01998035"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-007-0260-8"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1744.1744"},{"key":"CIT0097","first-page":"4074","volume":"130","author":"Strati P","year":"2017","journal-title":"Blood"},{"key":"CIT0098","unstructured":"National Cancer Institute; University of Texas MD Anderson Cancer\n      Center. Alisertib and romidepsin in treating patients       with relapsed or refractory B-cell or T-cell lymphomas.\n      ClinicalTrials.gov. Bethesda (MD):\n      National Library of Medicine (US). NLM Identifier:       NCT01897012. [cited 2019 Jan 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01897012."}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2019.1572746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T18:39:59Z","timestamp":1597516799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2019.1572746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,4]]}},"alternative-id":["10.1080\/14712598.2019.1572746"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2019.1572746","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}